Prostate cancer in India: Current perspectives and the way forward

R. Bhargavi,Barkha Khilwani,Bhumandeep Kour,Nidhi Shukla, Rajaguru Aradhya,Devendra Kumar Sharma, Maneesh Vijayvargiya,Abdul S. Ansari, V. Sugunakar, Praveen Mathur,Ashwani Kumar Mishra, Gopalakrishna Ramaswamy,Nripesh Sadasukhi,Jayaraman Valadi,Krishna Mohan Medicherla, Geetha B. Kumar, Rupert Ecker,Bhawana Bissa, T. C. Sadasukhi, Renuka Suravajhala,Nandita Mishra, Rune Mathiessen, P. N. Johri,Jyotsna Batra,Bipin Nair,Keshav K. Singh,Prashanth Suravajhala, N. K. Lohiya

Journal of Reproductive Healthcare and Medicine(2023)

引用 0|浏览2
暂无评分
摘要
Prostate cancer (PCa) is one of the burgeoning cancers worldwide. Of late, the number of cases in the Indian subcontinent has been doubling and the incidence as per the population-based cancer registries (PBCR) has increased at an alarming rate. In assessing the trends of PCa, there needs a statistical framework on incidence, comparing PBCRs vis-a-vis with hospital-based cancer registries not only to that of cohorts from India but also to that of West and other consortia. Our erstwhile pilot study on inferring whole-exome sequencing variants has yielded distinct polymorphisms in the Indian phenotype of PCa. There are impending challenges and gray areas that we discuss in this review in lieu of PCa pathogenesis and therapeutics.
更多
查看译文
关键词
prostate cancer,india
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要